The levels of IL-6 were found to be significantly associated with nonmotor symptoms, including psychosis, depression, anxiety, apathy, dopamine dysregulation syndrome, constipation, and lightheadedness on standing (LHON). Here, IL6 is linked to depressive symptom measurement.